296 related articles for article (PubMed ID: 22828014)
1. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
2. (1)H-MRS evaluation of therapeutic effect of neural stem cell transplantation on Alzheimer's disease in AβPP/PS1 double transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Li MH; Zhang W; Zang FC
J Alzheimers Dis; 2012; 28(1):71-80. PubMed ID: 21955813
[TBL] [Abstract][Full Text] [Related]
3. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
4. Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice.
Oberg J; Spenger C; Wang FH; Andersson A; Westman E; Skoglund P; Sunnemark D; Norinder U; Klason T; Wahlund LO; Lindberg M
Neurobiol Aging; 2008 Sep; 29(9):1423-33. PubMed ID: 17434239
[TBL] [Abstract][Full Text] [Related]
5. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
6. Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons.
Xu W; Zhan Y; Huang W; Wang X; Zhang S; Lei H
J Neurosci Res; 2010 Nov; 88(14):3155-60. PubMed ID: 20806406
[TBL] [Abstract][Full Text] [Related]
7. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
[TBL] [Abstract][Full Text] [Related]
8. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
9. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
10. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
11. Reduced hippocampal glutamate in Alzheimer disease.
Rupsingh R; Borrie M; Smith M; Wells JL; Bartha R
Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936
[TBL] [Abstract][Full Text] [Related]
12. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
13. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
[TBL] [Abstract][Full Text] [Related]
14. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
Penner J; Rupsingh R; Smith M; Wells JL; Borrie MJ; Bartha R
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):104-10. PubMed ID: 19833161
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy analysis of neurochemical changes in the atrophic hippocampus of APP/PS1 transgenic mice.
Liang S; Huang J; Liu W; Jin H; Li L; Zhang X; Nie B; Lin R; Tao J; Zhao S; Shan B; Chen L
Behav Brain Res; 2017 Sep; 335():26-31. PubMed ID: 28797599
[TBL] [Abstract][Full Text] [Related]
17. Multifaceted assessment of the APP/PS1 mouse model for Alzheimer's disease: Applying MRS, DTI, and ASL.
Shen Z; Lei J; Li X; Wang Z; Bao X; Wang R
Brain Res; 2018 Nov; 1698():114-120. PubMed ID: 30077647
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
19. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
20. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.
Chen SQ; Wang PJ; Ten GJ; Zhan W; Li MH; Zang FC
Dement Geriatr Cogn Disord; 2009; 28(6):558-66. PubMed ID: 20093832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
